Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
26.91
+0.04 (0.13%)
May 26, 2026, 2:53 PM EDT - Market open

Genmab Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,2041,326817999.61599.17
Depreciation & Amortization
-71604352.137.93
Stock-Based Compensation
-1281058563.1947.41
Other Adjustments
--107-337-45-56.85-120.66
Change in Receivables
--166-230116-305.57-154.3
Changes in Inventories
--9-1-8--
Changes in Accounts Payable
----40.7346.49
Changes in Income Taxes Payable
--460-50-155-227.85-113.47
Changes in Other Operating Activities
-525253218-2.3-109.65
Operating Cash Flow
-1,1861,1261,071563.06340.72
Operating Cash Flow Growth
-5.33%5.13%90.21%65.26%-67.73%
Capital Expenditures
--37-27-53-45.63-38.54
Purchases of Intangible Assets
--18-17-1--
Purchases of Investments
--995-1,256-1,582-1,396-2,388
Proceeds from Sale of Investments
-2,6221,6361,4511,0442,280
Payments for Business Acquisitions
--7,215-1,783---
Investing Cash Flow
--5,643-1,447-185-397.4-146.96
Long-Term Debt Issued
-5,500----
Net Long-Term Debt Issued (Repaid)
-5,500----
Issuance of Common Stock
-23192140.320.65
Repurchase of Common Stock
--430-560-81-143.36-76
Net Common Stock Issued (Repurchased)
--407-541-60-103.06-55.36
Other Financing Activities
--304-25-29-10.51-8.87
Financing Cash Flow
-4,789-566-89-113.56-64.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-5.5363-1282.62129.99
Net Cash Flow
-82332-88779752.1129.53
Free Cash Flow
-1,1491,0991,018517.44302.18
Free Cash Flow Growth
-4.55%7.96%96.74%71.23%-69.95%
FCF Margin
-30.89%35.21%42.59%24.78%23.48%
Free Cash Flow Per Share
-1.831.701.540.780.46
Levered Free Cash Flow
536,5531,368676601.78274.96
Unlevered Free Cash Flow
860.781,1551,207817525.17163.58
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q